Microbiological and immunological strategies for treatment of inflammatory bowel disease (Q34439861)

2 August 2017

1 reference

title

Microbiological and immunological strategies for treatment of inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

2 August 2017

0 references

author name string

L Steidler

series ordinal

1

1 reference

2 August 2017

1 November 2001

1 reference

2 August 2017

Microbes and Infection

1 reference

2 August 2017

3

1 reference

2 August 2017

1157-1166

1 reference

2 August 2017

13

1 reference

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Type 1 T-helper cell predominance in granulomas of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Staphylococcal enterotoxin B stimulates expansion of autoreactive T cells that induce apoptosis in intestinal epithelial cells: regulation of autoreactive responses by IL-10

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Novel treatments in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Influence of inflammatory bowel disease on intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Impaired bacterial flora in human excluded colon

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Identification of a novel bacterial sequence associated with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Rat intestinal epithelial cells present major histocompatibility complex allopeptides to primed T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Recent developments in the immunology of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Viral vectors expressing immunoregulatory cytokines to treat inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Antibodies to interleukin 12 abrogate established experimental colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Promising new agents for the treatment of inflammatory bowel disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

1 reference

7 January 2021

Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Interleukin 10 gene transfer prevents experimental colitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Transfer of interleukin-4 and interleukin-10 in patients with severe inflammatory bowel disease of the rectum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

PROBIOTICS: GROWTH-PROMOTING FACTORS PRODUCED BY MICROORGANISMS.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Influence of a synbiotic mixture consisting of Lactobacillus acidophilus 74-2 and a fructooligosaccharide preparation on the microbial ecology sustained in a simulation of the human intestinal microbial ecosystem (SHIME reactor).

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Oat beta-glucan and xylan hydrolysates as selective substrates for Bifidobacterium and Lactobacillus strains

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label Study

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Saccharomyces boulardii in maintenance treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Probiotics: a novel approach in the management of food allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

New types of antimicrobial compounds produced by Lactobacillus plantarum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Reduction of carriage of enterohemorrhagic Escherichia coli O157:H7 in cattle by inoculation with probiotic bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

The normal faecal microflora does not affect the adhesion of probiotic bacteria in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Interactions mediating bacterial translocation in the immature intestine

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Immune response to orally consumed antigens and probiotic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

The influence of chronic yogurt consumption on immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Amino Acid Degradation by a Lactobacillus plantarum Strain from Fish

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Protective and pathological roles of nitric oxide in endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Binding of aflatoxin B1 to bifidobacteria in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Binding of aflatoxin B1 alters the adhesion properties of Lactobacillus rhamnosus strain GG in a Caco-2 model

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Probiotic bacteria stimulate gut epithelial cell proliferation in rat

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Short chain fatty acids in the human colon

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

The colonic epithelium in ulcerative colitis: an energy-deficiency disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

Probiotic preparations dose-dependently increase net production rates of organic acids and decrease that of ammonia by pig cecal bacteria in batch culture

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901476-9

7 January 2021

10.1016/S1286-4579(01)01476-9

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11709296